Dr. Fardad Esmailian, MD

Dr. Esmailian practices at Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System.

Dr. Esmailian's NPI, 1861426314, was assigned on July 10, 2006. Dr. Esmailian graduated from George Washington University School of Medicine and Health Sciences in 1987. Dr. Esmailian holds California license G64353.

Dr. Esmailian's primary practice is Cedars-Sinai Medical Center, at 8700 Beverly Blvd, Los Angeles, CA 90048 in Los Angeles County. The practice phone is (310) 423-5000.

Dr. Esmailian's primary practice is Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System. The medical group on file is Cedars-Sinai Medical Center. Dmand AI also links Dr. Esmailian to 4 more home health agencies, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Esmailian practices, 6 sites in all. Vendor and product names are available with a free account.

Thoracic surgery (cardiothoracic vascular surgery) is Dr. Esmailian's primary specialty in the NPI Registry, under taxonomy code 208G00000X. Dr. Esmailian is board certified in thoracic and cardiac surgery by the American Board of Thoracic Surgery. Dr. Esmailian is licensed in California.

Dmand AI lists heart bypass surgery and heart valve surgery among the conditions Dr. Esmailian treats.

CMS data shows 417 Medicare services from Dr. Esmailian across 9 procedure codes in 2024, for 182 Medicare patients. Medicare paid $124,214 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 182 Medicare patients who saw Dr. Esmailian in 2024. The largest group is 65 to 74, with 94 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 40% are also on Medicaid. Their average risk score is 2.30, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Esmailian's median patient age at 68, with 30% women.

In 2024, Dr. Esmailian wrote 47 Medicare Part D claims. 87% of them were for generic drugs. CMS names the drug for 23 of them, across 2 drugs with 11 or more claims each, at $9,978 in total drug cost. In 2020, CMS named 24 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Esmailian for performance year 2024, reported as part of a group. Dr. Esmailian accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Esmailian as offering telehealth. CMS counts 68 procedures of coronary artery bypass graft (cabg) by Dr. Esmailian, more than 98% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 6 papers to Dr. Esmailian, published from 2017 to 2022. Dr. Esmailian's most frequent co-authors are Jon A. Kobashigawa, MD, Lawrence S.c. Czer, MD and Dominick Joseph Megna, MD.

Dmand AI links Dr. Esmailian to 1 clinical trial. Conditions studied include Heart Failure and Heart Diseases.

CMS Open Payments shows 161 general payments to Dr. Esmailian from 26 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 36% of the total. Biom'Up SA paid the most, $7,404. It also lists 5 research payments totaling $563 in 2019.

Dmand AI lists 4 awards for Dr. Esmailian, most recently Top Doctors:LA Area in 2013.

Dr. Esmailian graduated from George Washington University School of Medicine and Health Sciences in 1987. Dr. Esmailian is a member of AATS, ACS, ISHLT and STS.

Dr. Esmailian is in network with 14 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.